Biofrontera affirms its previously announced expectations for full-year 2023 growth in revenue to be at least 25% compared with 2022.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BFRI:
